New hope for kids with Hard-to-Treat kawasaki disease
NCT ID NCT01596335
Summary
This study tested a second treatment option for children with Kawasaki disease who did not get better after the standard first therapy. It compared a new drug called TA-650 against an existing control drug to see which was better at reducing fever and preventing heart complications. The goal was to find a safe and effective backup treatment for these difficult cases.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KAWASAKI DISEASE REFRACTORY TO INITIAL THERAPY WITH INTRAVENOUS IMMUNOGLOBULIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational site
Chugoku, Japan
-
Investigational site
Chūbu, Japan
-
Investigational site
Hokkaido, Japan
-
Investigational site
Kanto, Japan
-
Investigational site
Kyushu, Japan
-
Investigational site
Shinetu, Japan
-
Investigational site
Tōhoku, Japan
-
Investigational site
Tōkai, Japan
Conditions
Explore the condition pages connected to this study.